- Home
- OCUL vs EVV Comparison
OCUL vs EVV Comparison
Compare OCUL & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- EVV
- Stock Information
- Founded
- OCUL 2006
- EVV 2003
- Country
- OCUL United States
- EVV United States
- Employees
- OCUL N/A
- EVV N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- EVV Finance/Investors Services
- Sector
- OCUL Health Care
- EVV Finance
- Exchange
- OCUL Nasdaq
- EVV Nasdaq
- Market Cap
- OCUL 1.2B
- EVV 1.2B
- IPO Year
- OCUL 2014
- EVV N/A
- Fundamental
- Price
- OCUL $7.18
- EVV $10.06
- Analyst Decision
- OCUL Strong Buy
- EVV
- Analyst Count
- OCUL 9
- EVV 0
- Target Price
- OCUL $16.22
- EVV N/A
- AVG Volume (30 Days)
- OCUL 1.8M
- EVV 323.7K
- Earning Date
- OCUL 03-03-2025
- EVV 01-01-0001
- Dividend Yield
- OCUL N/A
- EVV 9.66%
- EPS Growth
- OCUL N/A
- EVV N/A
- EPS
- OCUL N/A
- EVV N/A
- Revenue
- OCUL $63,723,000.00
- EVV N/A
- Revenue This Year
- OCUL $14.02
- EVV N/A
- Revenue Next Year
- OCUL $15.47
- EVV N/A
- P/E Ratio
- OCUL N/A
- EVV N/A
- Revenue Growth
- OCUL 9.03
- EVV N/A
- 52 Week Low
- OCUL $4.06
- EVV $8.52
- 52 Week High
- OCUL $11.78
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- OCUL 43.57
- EVV 44.52
- Support Level
- OCUL $7.36
- EVV $10.02
- Resistance Level
- OCUL $8.04
- EVV $10.18
- Average True Range (ATR)
- OCUL 0.45
- EVV 0.07
- MACD
- OCUL -0.03
- EVV 0.00
- Stochastic Oscillator
- OCUL 6.54
- EVV 35.71
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.